178 related articles for article (PubMed ID: 19019939)
1. The dot-and-fleck retinopathy of X linked Alport syndrome is independent of complement factor H (CFH) gene polymorphisms.
Liu J; Colville D; Wang YY; Baird PN; Guymer RH; Savige J
Br J Ophthalmol; 2009 Mar; 93(3):379-82. PubMed ID: 19019939
[TBL] [Abstract][Full Text] [Related]
2. The retinal "lozenge" or "dull macular reflex" in Alport syndrome may be associated with a severe retinopathy and early-onset renal failure.
Colville D; Wang YY; Tan R; Savige J
Br J Ophthalmol; 2009 Mar; 93(3):383-6. PubMed ID: 19019929
[TBL] [Abstract][Full Text] [Related]
3. Genotype-phenotype correlation of age-related macular degeneration: influence of complement factor H polymorphism.
Droz I; Mantel I; Ambresin A; Faouzi M; Schorderet DF; Munier FL
Br J Ophthalmol; 2008 Apr; 92(4):513-7. PubMed ID: 18211923
[TBL] [Abstract][Full Text] [Related]
4. Alport syndrome. Molecular genetic aspects.
Hertz JM
Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the Y402H variant of the complement factor H gene in age-related macular degeneration.
Baird PN; Islam FM; Richardson AJ; Cain M; Hunt N; Guymer R
Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4194-8. PubMed ID: 17003406
[TBL] [Abstract][Full Text] [Related]
6. Absence of ocular manifestations in autosomal dominant Alport syndrome associated with haematological abnormalties.
Colville D; Wang YY; Jamieson R; Collins F; Hood J; Savige J
Ophthalmic Genet; 2000 Dec; 21(4):217-25. PubMed ID: 11135492
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the peripheral retinopathy in X-linked and autosomal recessive Alport syndrome.
Shaw EA; Colville D; Wang YY; Zhang KW; Dagher H; Fassett R; Guymer R; Savige J
Nephrol Dial Transplant; 2007 Jan; 22(1):104-8. PubMed ID: 17071739
[TBL] [Abstract][Full Text] [Related]
8. Gene-environment interaction in progression of AMD: the CFH gene, smoking and exposure to chronic infection.
Baird PN; Robman LD; Richardson AJ; Dimitrov PN; Tikellis G; McCarty CA; Guymer RH
Hum Mol Genet; 2008 May; 17(9):1299-305. PubMed ID: 18203751
[TBL] [Abstract][Full Text] [Related]
9. Complement factor H and hemicentin-1 in age-related macular degeneration and renal phenotypes.
Thompson CL; Klein BE; Klein R; Xu Z; Capriotti J; Joshi T; Leontiev D; Lee KE; Elston RC; Iyengar SK
Hum Mol Genet; 2007 Sep; 16(17):2135-48. PubMed ID: 17591627
[TBL] [Abstract][Full Text] [Related]
10. The spectrum of phenotypes caused by variants in the CFH gene.
Boon CJ; van de Kar NC; Klevering BJ; Keunen JE; Cremers FP; Klaver CC; Hoyng CB; Daha MR; den Hollander AI
Mol Immunol; 2009 May; 46(8-9):1573-94. PubMed ID: 19297022
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms in C2, CFB and C3 are associated with progression to advanced age related macular degeneration associated with visual loss.
Francis PJ; Hamon SC; Ott J; Weleber RG; Klein ML
J Med Genet; 2009 May; 46(5):300-7. PubMed ID: 19015224
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of combining complement factor H and C-reactive protein genetic profiles for predicting myocardial infarction (from the Rotterdam Study).
Kardys I; de Maat MP; Klaver CC; Despriet DD; Uitterlinden AG; Hofman A; de Jong PT; Witteman JC
Am J Cardiol; 2007 Aug; 100(4):646-8. PubMed ID: 17697822
[TBL] [Abstract][Full Text] [Related]
13. LOC387715/HTRA1 and complement factor H variants in patients with age-related macular degeneration seen at the mayo clinic.
Pulido JS; Peterson LM; Mutapcic L; Bryant S; Highsmith WE
Ophthalmic Genet; 2007 Dec; 28(4):203-7. PubMed ID: 18161619
[TBL] [Abstract][Full Text] [Related]
14. Ocular features in Alport syndrome: pathogenesis and clinical significance.
Savige J; Sheth S; Leys A; Nicholson A; Mack HG; Colville D
Clin J Am Soc Nephrol; 2015 Apr; 10(4):703-9. PubMed ID: 25649157
[TBL] [Abstract][Full Text] [Related]
15. The common Y402H variant in complement factor H gene is not associated with susceptibility to myocardial infarction and its related risk factors.
Stark K; Neureuther K; Sedlacek K; Hengstenberg W; Fischer M; Baessler A; Wiedmann S; Jeron A; Holmer S; Erdmann J; Schunkert H; Hengstenberg C
Clin Sci (Lond); 2007 Aug; 113(4):213-8. PubMed ID: 17472578
[TBL] [Abstract][Full Text] [Related]
16. Association of complement factor H Y402H polymorphism with phenotype of neovascular age related macular degeneration in Israel.
Chowers I; Cohen Y; Goldenberg-Cohen N; Vicuna-Kojchen J; Lichtinger A; Weinstein O; Pollack A; Axer-Siegel R; Hemo I; Averbukh E; Banin E; Meir T; Lederman M
Mol Vis; 2008; 14():1829-34. PubMed ID: 18852870
[TBL] [Abstract][Full Text] [Related]
17. Alport retinopathy results from "severe" COL4A5 mutations and predicts early renal failure.
Tan R; Colville D; Wang YY; Rigby L; Savige J
Clin J Am Soc Nephrol; 2010 Jan; 5(1):34-8. PubMed ID: 19965530
[TBL] [Abstract][Full Text] [Related]
18. Complement Factor H polymorphism Y402H associates with inflammation, visual acuity, and cardiovascular mortality in the elderly population at large.
Mooijaart SP; Koeijvoets KM; Sijbrands EJ; Daha MR; Westendorp RG
Exp Gerontol; 2007 Nov; 42(11):1116-22. PubMed ID: 17869048
[TBL] [Abstract][Full Text] [Related]
19. Alport syndrome. A review of the ocular manifestations.
Colville DJ; Savige J
Ophthalmic Genet; 1997 Dec; 18(4):161-73. PubMed ID: 9457747
[TBL] [Abstract][Full Text] [Related]
20. Complement factor H gene polymorphism and risk of cardiovascular disease in end-stage renal disease patients.
Buraczynska M; Ksiazek P; Zukowski P; Benedyk-Lorens E; Orlowska-Kowalik G
Clin Immunol; 2009 Aug; 132(2):285-90. PubMed ID: 19428307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
